SCHEMBL8682240

SCHEMBL8682240

CCCOC(=O)OC1CCCC[N]1

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPM1B O75688 1/20 0.33
PTPN1 P18031 1/20 0.33
PPP1CC P36873 1/20 0.33
NAAA Q02083 2/20 0.32
EPHX1 P07099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8681186 0.95 PPM1B (0.33) PPM1BPTPN1PPP1CC
SCHEMBL8701965 0.91 ALDH1A1 (0.38) NAAA
SCHEMBL8682200 0.88 NAAA (0.41) NAAAEPHX1
SCHEMBL8682098 0.88 NAAA (0.41) NAAAEPHX1
SCHEMBL8681178 0.88 NAAA (0.41) NAAAEPHX1
SCHEMBL8683098 0.88 NAAA (0.41) NAAAEPHX1
SCHEMBL8682191 0.88 NAAA (0.41) NAAAEPHX1
SCHEMBL8681285 0.87 ALDH1A1 (0.40) EPHX1
SCHEMBL8683223 0.86 ALDH1A1 (0.39) NAAA
SCHEMBL8681136 0.84 NAAA (0.39) NAAAEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5843983-A Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1998-12-01 US disclosed
EP-0844000-A1 Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis SANKYO COMPANY LIMITED (JP) 1998-05-27 EP disclosed
EP-0790235-A1 Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses SANKYO COMPANY LIMITED (JP) 1997-08-20 EP disclosed
US-5556864-A TREATMENT OF CIRCULATORY DISEASES AND PSYCHOSIS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
EP-0600717-A1 Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis SANKYO COMPANY LIMITED (JP) 1994-06-08 EP disclosed